Joseph Awarded $15 million SFRN Grant
Researchers awarded $15 million to study cardiovascular-kidney-metabolic syndrome in women
The American Heart Association funds scientists at Augusta University, Massachusetts General Hospital and The Ohio State University to study the different ways in which risk factors for cardiovascular and kidney diseases impact women
April 22, 2025
Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University will lead a $15 million project dedicated to studying the various ways that risk factors for cardiovascular and kidney diseases impact women. The American Heart Association’s Strategically Focused Research Network (SFRN) on Cardiovascular Kidney Metabolic Syndrome: Heterogeneity in Women aims to learn why women may be more likely to develop cardiovascular and kidney diseases due to certain unique risk factors and life stages.
The American Heart Association, a global force changing the future of health for all, funds Strategically Focused Research Networks (SFRN) as part of its mission to be a relentless force for a world of longer, healthier lives. Research teams apply for the program’s four-year grants with novel and innovative ideas to better understand cardiovascular diseases impacted by each SFRN focus, the latest of which is cardiovascular-kidney-metabolic (CKM) syndrome.
CKM syndrome is a clinical term that describes the combined health effects of heart disease, kidney disease, diabetes and obesity, which puts people at high risk for heart attack, stroke and heart failure. According to the American Heart Association’s 2025 Heart Disease and Stroke Statistics, about 1 in 3 U.S. adults has at least three components of CKM syndrome, which include high blood pressure, abnormal cholesterol, high blood glucose (sugar), impaired kidney function and excess body weight.
“Understanding the interconnections of cardiovascular, kidney and metabolic conditions including diabetes and obesity is critical, especially as many of the contributing risk factors are on the rise,” said Keith Churchwell, M.D., FAHA, American Heart Association volunteer president, an associate clinical Professor of Medicine at Yale School of Medicine in New Haven, Connecticut and adjunct Associate Professor of Medicine at the Vanderbilt School of Medicine in Nashville, Tennessee. “Women are historically underrepresented in clinical research, so we don’t have a solid understanding of why many of these risk factors are often more prevalent in and impact women differently than men. Learning more about the biological significance of certain life cycles including menopause and pregnancy, as well as societal factors and the roles of community, relationships and individual behaviors could provide important insight to foster the development of targeted preventive strategies, tailored therapeutic approaches and ultimately help change the future of health for all.”